Hiromi Yatsuji

发表

Selection of a virus strain resistant to entecavir in a nucleoside-naive patient with hepatitis B of genotype H.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Prolonged hepatitis after acute infection with genotype H hepatitis B virus.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Internal medicine.

Poor Response to Pegylated Interferon and Ribavirin in Older Women Infected with Hepatitis C Virus of Genotype 1b in High Viral Loads

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Digestive Diseases and Sciences.

Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Journal of medical virology.

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin

Yusuke Nakamura, K. Chayama, Yoshiyuki Suzuki, 2010, Hepatology.

Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 2a High Viral Load and Virological Response to Interferon-Ribavirin Combination Therapy

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Intervirology.

A matched case‐controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Journal of medical virology.

Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP‐424), pegylated interferon and ribavirin for 12 weeks

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

The efficacy of interferon-beta monotherapy for elderly patients with type C hepatitis of genotype 2.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Internal medicine.

Virological and Biochemical Features in Elderly HCV Patients with Hepatocellular Carcinoma: Amino Acid Substitutions in HCV Core Region as Predictor of Mortality after First Treatment

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Intervirology.

The Efficacy of 24-Week Interferon Monotherapy for Type C Liver Cirrhosis in Japanese Patients with Genotype 1b and Low Virus Load

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Intervirology.

Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Journal of medical virology.

Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Journal of medical virology.

Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma: differences between young and elderly patients

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Journal of Gastroenterology.

Dual effect of APOBEC 3 G on Hepatitis B virus

M. Imamura, N. Hiraga, K. Chayama, 2007 .

Prediction of Response to Pegylated Interferon and Ribavirin in Hepatitis C by Polymorphisms in the Viral Core Protein and Very Early Dynamics of Viremia

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Intervirology.

Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patients.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, The American journal of medicine.

Losartan reduces the onset of type 2 diabetes in hypertensive Japanese patients with chronic hepatitis C

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Journal of medical virology.

Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report

Yoshiyuki Suzuki, Y. Torisu, M. Kobayashi, 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levels

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Scandinavian journal of gastroenterology.

Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Journal of gastroenterology and hepatology.

New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, World journal of gastroenterology.

HBcrAg is a predictor of post‐treatment recurrence of hepatocellular carcinoma during antiviral therapy

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, The American journal of medicine.

Prolonged‐efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Journal of medical virology.

Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Journal of medical virology.

Serum KL-6 level is elevated in chronic hepatitis C patients with combination therapy of pegylated interferon and ribavirin.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Internal medicine.

Prolonged‐interferon therapy reduces hepatocarcinogenesis in aged‐patients with chronic hepatitis C

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Journal of medical virology.

New ablation procedure for a radiofrequency liver tissue coagulation system using an expandable needle

K. Ikeda, M. Kobayashi, H. Kumada, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Journal of medical virology.

Successful treatment of an entecavir‐resistant hepatitis B virus variant

M. Imamura, N. Hiraga, K. Chayama, 2007, Journal of medical virology.

Emergence of a Novel Lamivudine-Resistant Hepatitis B Virus Variant with a Substitution Outside the YMDD Motif

M. Imamura, N. Hiraga, K. Chayama, 2006, Antimicrobial Agents and Chemotherapy.

Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients with genotype 1b and high virus load.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Internal medicine.

Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Internal medicine.

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholesterol levels.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Journal of hepatology.

Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Journal of hepatology.

Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha‐fetoprotein in patients without hepatocellular carcinoma

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Journal of medical virology.

Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevir.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Journal of Clinical Virology.

Virological Response and Hepatocarcinogenesis in Lamivudine-Resistant Hepatitis B Virus Genotype C Patients Treated with Lamivudine plus Adefovir Dipivoxil

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Intervirology.

Influence of HMG-CoA reductase inhibitor to virological response of peginterferon/ribavirin combination therapy in chronic hepatitis C

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008 .

Low hepatitis B virus core-related antigen is a predictor of absence in post-treatment recurrence of hepatocellular carcinoma during antiviral therapy

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009 .

Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Journal of medical virology.

Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

Serum HBV RNA is a predictor of early emergence of the YMDD mutant in patients treated with lamivudine

M. Imamura, N. Hiraga, K. Chayama, 2007, Hepatology.

Predictive factors of advanced recurrence after curative resection of small hepatocellular carcinoma

Yoshiyuki Suzuki, K. Ikeda, M. Kobayashi, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Changes in viral loads of lamivudine‐resistant mutants during entecavir therapy

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy of entecavir treatment for lamivudine‐resistant hepatitis B over 3 years: Histological improvement or entecavir resistance?

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Journal of gastroenterology and hepatology.

Clinical and virological effects of long‐term (over 5 years) lamivudine therapy

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Journal of medical virology.

Necessities of interferon therapy in elderly patients with chronic hepatitis C.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, The American journal of medicine.

Efficacy of switching to entecavir monotherapy in Japanese lamivudine‐pretreated patients

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Journal of gastroenterology and hepatology.

Increase of rtA181T mutant strains during entecavir therapy for a patient with chronic hepatitis B virus infection

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010 .

Extending Combination Therapy with Peginterferon plus Ribavirin for Genotype 2 Chronic Hepatitis C Virological Responders: A Pilot Study of 7 Cases

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Intervirology.

Combination therapy of peginterferon and ribavirin for chronic hepatitis C patients with genotype 1b and low-virus load.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Internal medicine.

Efficacy in Patients with Dose Reduction in Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis C

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Intervirology.

Suitable treatment period in patients with virological response during combination therapy of peginterferon and ribavirin for chronic hepatitis C.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Internal medicine.

The efficacy of short-term interferon-beta therapy for chronic hepatitis C patients with low virus load.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Internal medicine.

The efficacy of short-term interferon-beta therapy for type C cirrhotic patients with genotype 2a and low virus load.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Internal medicine.

Natural human interferon beta plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus and a high viral load.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Internal medicine.

Change of hepatitis B virus genotypes in acute and chronic infections in Japan

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Journal of medical virology.

Dual effect of APOBEC3G on Hepatitis B virus.

M. Imamura, N. Hiraga, K. Chayama, 2007, The Journal of general virology.

Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients with genotype 2 and high virus load.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Internal medicine.

Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Hepatology.

Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Journal of medical virology.

Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Hepatology.

Amino Acid Substitution in HCV Core Region and Genetic Variation near the IL28B Gene Affect Viral Dynamics during Telaprevir, Peginterferon and Ribavirin Treatment

Yusuke Nakamura, K. Chayama, Yoshiyuki Suzuki, 2012, Intervirology.

High serum des‐gamma‐carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Cancer.

Hepatocarcinogenesis following HCV RNA eradication by interferon in chronic hepatitis patients.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Internal medicine.

Evaluation of long‐term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

Association of HLA-DR14 with the Treatment Response in Japanese Patients with Autoimmune Hepatitis

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Digestive Diseases and Sciences.

An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Intervirology.

Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Journal of medical virology.

Randomized controlled trial for the efficacy of hepatic arterial occlusion during radiofrequency ablation for small hepatocellular carcinoma – direct ablative effects and a long‐term outcome

K. Ikeda, M. Kobayashi, H. Kumada, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Efficacy and anticarcinogenic activity of interferon for hepatitis C virus‐related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

Predictive factors of advanced recurrence after curative resection of small hepatocellular carcinoma

Yoshiyuki Suzuki, K. Ikeda, M. Kobayashi, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP‐424), pegylated interferon and ribavirin for 12 weeks

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Journal of hepatology.

Influence of gender to efficacy of interferon/ribavirin combination therapy in chronic hepatitis C patients in Japan

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007 .